Why the Future of Marijuana Legalization Remains Hazy Despite High Public Support
Regulatory uncertainty cannabis research creates significant barriers to clinical cannabis studies and patient care protocols. Despite high public support, policy implementation remains fragmented and inconsistent. This disconnect affects patient access…
What Travelers Need to Know About TSA Rules on CBD Gummies in 2026
TSA rules on CBD gummies are evolving in 2026, affecting travelers carrying these products. Patients using CBD therapeutically must understand travel regulations to avoid disruptions. This article provides essential insights on TSA rules on CBD gummies…
Constitutional Issues in Cannabis Law: Rhode Island Analysis
Constitutional cannabis challenges directly impact patient access to medical cannabis and clinical practice frameworks. Legal uncertainties can disrupt treatment protocols and require clinicians to adapt. Understanding these challenges is essential for…
Alabama’s First Medical Cannabis Dispensary Launching in May 2024
The Alabama medical cannabis dispensary launch in May 2024 represents a historic step in expanding legal patient access. This launch introduces regulated cannabis access for qualifying patients under state oversight. Physicians and patients alike will…
Federal Judge Blocks Rhode Island Cannabis Business License Lottery Amid Legal Challenge
A federal judge has blocked the Rhode Island cannabis business license lottery due to legal challenges over residency requirements. This decision highlights conflicts between state cannabis licensing frameworks and federal oversight. Patients and…
Pascagoula City Council Expands Smoke-Free Ordinance to Include Cannabis and Vapes
The local cannabis smoke-free ordinance in Pascagoula now includes vaping devices and cannabis in public spaces. This expansion affects patient consumption patterns and clinical counseling. Healthcare providers should be aware of these evolving…
US System For Classifying Marijuana And Other Drugs Does ‘Immense Damage,’ Former DEA Official Says
The controlled substances act scheduling system critically affects marijuana research and patient access. Former DEA officials highlight how this system creates barriers to clinical practice. Understanding these impacts is essential for anticipating…
Scientists Gene Hacked a Plant to Produce Multiple Psychoactive Drugs
This article highlights biotechnology research psychedelics involving gene-hacked plants that produce multiple psychoactive compounds. The development may improve production consistency and cost-effectiveness. While promising, these compounds remain…
New York’s Growing Cannabis Treatment Gap and Access Barriers
Cannabis treatment access barriers in New York are creating significant challenges for patients seeking medical cannabis. These barriers contribute to healthcare inequities and limit patient access to licensed programs. Addressing these access issues is…
Ban on Rescue Dogs from High Rabies Risk Countries to Continue, CFIA Confirms
The CFIA's rabies prevention policy highlights public health risk management by banning rescue dogs from countries at risk. This regulatory approach prioritizes safety over access concerns. Understanding such policies aids cannabis clinicians in grasping…